Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy.

Jiang ChenZohreh AmoozgarXin LiuShuichi AokiZelong LiuSarah ShinAya MatsuiZhangya PuPin-Ji LeiMeenal DattaLingling ZhuZhiping RuanLei ShiDaniel StaiculescuKoetsu InoueLance L MunnDai FukumuraPeigen HuangNabeel BardeesyWon Jin HoRakesh K Jain Dan G Duda

Published in: bioRxiv : the preprint server for biology (2023)

Immune microenvironment reprogramming by chemotherapy and priming using CTLA-4 blockade render ICCs responsive to anti-PD-1 immunotherapy.

Keyphrases

stem cells
locally advanced
cancer therapy
squamous cell carcinoma
rectal cancer
radiation therapy